[Aclacinomycin A: a new antitumor antibiotic].
D015250:Aclarubicin; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000096:biosynthesis / Q000627:therapeutic use* / Q000633:toxicity; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D002986:Clinical Trials as Topic; D006224:Cricetinae; D003470:Culture Media / Q000378:metabolism; D004317:Doxorubicin / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D004351:Drug Resistance; D006321:Heart / Q000187:drug effects; D006801:Humans; D051379:Mice; D009279:Naphthacenes / Q000096:biosynthesis / Q000627:therapeutic use / Q000633:toxicity; D009369:Neoplasms / Q000188:drug therapy; D009374:Neoplasms, Experimental / Q000188:drug therapy; D051381:Rats; D013302:Streptomyces / Q000378:metabolism; D013329:Structure-Activity Relationship
D000903:Antibiotics, Antineoplastic; D003470:Culture Media; D009279:Naphthacenes; D015250:Aclarubicin; D004317:Doxorubicin
Aklatsinomitsin A--novyĭ protivoopukholevyĭ antibiotik.